Predicting drug safety and communicating risk: benefits of a Bayesian approach
S. E. Lazic, N. Edmunds, C. E. Pollard
This paper advocates for Bayesian methods in drug safety prediction, using hERG-mediated QT prolongation as a case study, and provides code for implementation.
bioRxiv · Nov 1, 2017Pharmacology & Toxicology